$0.658500
0.0813.73%
Last update: 2:59 PM
15 minutes delayed
Comments
Loading...
ImmunoPrecise Antibodies (IPA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestImmunoPrecise Antibodies (NASDAQ:IPA) Stock Quotes, Forecast and News Summary
ImmunoPrecise Antibodies Stock (NASDAQ: IPA) stock price, news, charts, stock research, profile.
| Open | $0.58 |
| Close | - |
| Volume / Avg. | 375.88K / 98.88K |
| Day Range | $0.57 - $0.68 |
| 52 Wk Range | 0.53 - 2.60 |
| Market Cap | $18.38M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 44 |
| Short Interest | 0.41% |
| Days to Cover | 1.2 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
Healthcare
Industry
N/A
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industr...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy ImmunoPrecise Antibodies (IPA) stock?
You can purchase shares of ImmunoPrecise Antibodies (NASDAQ:IPA) through any online brokerage.
Who are ImmunoPrecise Antibodies (IPA) competitors?
There are no as such competitors for ImmunoPrecise Antibodies.
What is the forecast, or price target, for ImmunoPrecise Antibodies (IPA) stock?
ImmunoPrecise Antibodies has a consensus price target of $6.00.
What is the current price for ImmunoPrecise Antibodies (IPA)?
The stock price for ImmunoPrecise Antibodies (NASDAQ: IPA) is $0.5632 last updated September 18, 2024 at 8:20 AM EDT.
Does ImmunoPrecise Antibodies (IPA) pay a dividend?
There are no upcoming dividends for ImmunoPrecise Antibodies.
When is ImmunoPrecise Antibodies (NASDAQ:IPA) reporting earnings?
ImmunoPrecise Antibodies’s Q2 earnings are confirmed for Thursday, December 12, 2024.
Is ImmunoPrecise Antibodies (IPA) going to split?
There is no upcoming split for ImmunoPrecise Antibodies.
What sector and industry does ImmunoPrecise Antibodies (IPA) operate in?
ImmunoPrecise Antibodies is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.